Systemic application of sirolimus prevents neointima formation not via a direct anti-proliferative effect but via its anti-inflammatory properties

Saved in:
Persons: Daniel, Jan-Marcus [Author]; Dutzmann, Jochen [Author]; Brunsch, Hannes [Author]; Bauersachs, Johann [Author]; Braun-Dullaeus, Ruediger C. [Author]; Sedding, Daniel [Author]
Format: eArticle
Language(s):English
Publication:2017
Part of:International journal of cardiology 238(2017), Seite 79-91
ISSN:1874-1754
DOI:10.1016/j.ijcard.2017.03.052